High-flow nasal cannula during pulmonary rehabilitation for people with chronic obstructive pulmonary disease: A systematic review and meta-analysis.

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an increasingly concerning global public health issue due to its high burden of morbidity and mortality. Pulmonary rehabilitation (PR) is a comprehensive intervention to improve patients' physical and psychological conditions, commonly involving oxygen supplementation. The potential benefits of high-flow nasal cannula (HFNC) have recently sparked interest as oxygen therapy. In this context, this study aims to assess the effects of HFNC during the exercise training component of a PR program in people with COPD. METHODS: Systematic review (CRD42022330929). We included randomised controlled trials (RCTs), including crossover RCTs with adults with stable COPD. We included trials using oxygen therapy with HFNC during the exercise training component of a PR programme. PRIMARY OUTCOMES: disease-specific health-related quality of life (HRQoL), exercise capacity (EC) and adverse events. SECONDARY OUTCOMES: treatment adherence, breathlessness and future exacerbations. RESULTS: We included five studies with 300 participants with moderate to severe COPD. The certainty of the evidence was primarily low or very low for all outcomes of interest due to risk of bias, inconsistency or imprecision. HFNC has little to no difference in HRQoL (4 studies, 129 participants, MD 0.17, 95% CI -1.20 to 1.54; I2 50%). HFNC may result in little to no difference in EC (3 studies, 212 participants, mean difference 18.73, 95% CI -20.49 to 28.94; I2 56%), and we are uncertain about the effect of HFNC on breathlessness (4 studies; 244 participants, MD of -0.07, 95% CI -0.4 to 0.26; I2 63%). Only one study with 44 participants reported a participant's withdrawal because of progressive dyspnoea during lower limb exercise. CONCLUSIONS: We are uncertain about the effect of HFNC during the exercise component of a PR programme in HRQoL, EC or dyspnoea compared to usual care or conventional supplementary oxygen. Non-domiciliary oxygen patients showed improvements in HRQoL, EC and dyspnoea.

Evidence-Informed Update of Argentina's Health Benefit Package: Application of a Rapid Review Methodology.

OBJECTIVES: Argentina has a fragmented healthcare system with social security covering almost two thirds of the population. Its benefit package-called compulsory medical program (PMO; by its Spanish acronym Programa Médico Obligatorio)-has not been formally and widely updated since 2005. However, laws, clinical practice guidelines (CPGs), and a high-cost technology reimbursement fund complement it. Our objective was to comprehensively review such a PMO and propose an update considering the corresponding complementary sources. METHODS: We followed four steps: (i) identification of health technologies from the current PMO and complementary sources, (ii) prioritization, (iii) assessment through rapid health technology assessment (HTA), and (iv) appraisal and recommendations. We evaluated three value domains: quality of evidence, net benefit, and economics, which were summarized in a five-category recommendation traffic-light scale ranging from a strong recommendation in favor of inclusion to a strong recommendation for exclusion. RESULTS: Eight hundred fifty technologies were identified; 164 of those, considered as high priority, were assessed through rapid HTAs. Those technologies mentioned in laws and CPGs were mostly outpatient essential medicines, whereas those from the reimbursement system were mostly high-cost drugs; of these 101 technologies, 50 percent were recommended to be kept in the PMO. The other 63 (identified by the Superintendence of Health Services, technology producers, and patients) were mostly medical procedures and high-cost drugs; only 25 percent of those resulted in a favorable recommendation. CONCLUSIONS: A methodology based on four clearly identified steps was used to carry out a comprehensive review of an outdated and fragmented benefit package. The use of rapid HTAs and a traffic-light recommendation framework facilitated the deliberative evidence-based update.

Implementing Strategies at the Workplace Level to Increase Colorectal Cancer Screening Uptake in Argentina: A Controlled Interrupted Time-series Study.

Colorectal cancer is the third most common neoplasm. The immunochemical fecal occult blood test (iFOBT) is recommended for screening. The worksite setting has great potential to deliver preventive interventions. We aimed to design and evaluate the feasibility and potential impact of a multicomponent strategy in a workplace [Internal Revenue Agency of the Province of Buenos Aires (ARBA from its acronym in Spanish "Agencia de Recaudación de Buenos Aires") in Argentina].We used a quasi-experimental research design, a controlled interrupted time-series (ITS). The study involved: (i) a preintervention period (July 2015-September 2018); and (ii) an intervention period (October 2018-February 2019). We used semi-structured interviews and focus groups to design the intervention and to ensure feasibility and implementability. We fitted segmented linear regression models to evaluate changes in the monthly rates per 10,000 tests done in ARBA employees and controlling for the proportion of tests done in non-ARBA workers. A total of 1,552 ARBA employees aged 50 or more participated. Overall, iFOBT mean uptake rates were 16 times higher in the intervened during the five-month intervention period, remaining statistically significant after adjusting by the proportion of tests done in the control group (P < 0.001). The effect was higher in women aged 50 to 59 years. Activities were suspended due to the COVID-19 pandemic. A multifaceted workplace-based intervention proved to be feasible and acceptable to increase the uptake of colorectal cancer screening in employees of Argentina. Achieving high implementation rates requires building a healthy relationship with the partner organization, adding their values and views, and establishing agreed-upon mechanisms. PREVENTION RELEVANCE: Employee-facing multifaceted worksite cancer screening interventions are a valuable means to increase knowledge and utilization of workers. The controlled ITS showed that colorectal cancer screening mean uptake rates were 16 times higher in the intervened versus the control population during the intervention period, particularly among women aged 50 to 75.

Reducing medication errors for adults in hospital settings.

BACKGROUND: Medication errors are preventable events that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional or patient. Medication errors in hospitalised adults may cause harm, additional costs, and even death. OBJECTIVES: To determine the effectiveness of interventions to reduce medication errors in adults in hospital settings. SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase, five other databases and two trials registers on 16 January 2020.  SELECTION CRITERIA: We included randomised controlled trials (RCTs) and interrupted time series (ITS) studies investigating interventions aimed at reducing medication errors in hospitalised adults, compared with usual care or other interventions. Outcome measures included adverse drug events (ADEs), potential ADEs, preventable ADEs, medication errors, mortality, morbidity, length of stay, quality of life and identified/solved discrepancies. We included any hospital setting, such as inpatient care units, outpatient care settings, and accident and emergency departments. DATA COLLECTION AND ANALYSIS: We followed the standard methodological procedures expected by Cochrane and the Effective Practice and Organisation of Care (EPOC) Group. Where necessary, we extracted and reanalysed ITS study data using piecewise linear regression, corrected for autocorrelation and seasonality, where possible.  MAIN RESULTS: We included 65 studies: 51 RCTs and 14 ITS studies, involving 110,875 participants. About half of trials gave rise to 'some concerns' for risk of bias during the randomisation process and one-third lacked blinding of outcome assessment. Most ITS studies presented low risk of bias. Most studies came from high-income countries or high-resource settings. Medication reconciliation -the process of comparing a patient's medication orders to the medications that the patient has been taking- was the most common type of intervention studied. Electronic prescribing systems, barcoding for correct administering of medications, organisational changes, feedback on medication errors, education of professionals and improved medication dispensing systems were other interventions studied. Medication reconciliation Low-certainty evidence suggests that medication reconciliation (MR) versus no-MR may reduce medication errors (odds ratio [OR] 0.55, 95% confidence interval (CI) 0.17 to 1.74; 3 studies; n=379). Compared to no-MR, MR probably reduces ADEs (OR 0.38, 95%CI 0.18 to 0.80; 3 studies, n=1336 ; moderate-certainty evidence), but has little to no effect on length of stay (mean difference (MD) -0.30 days, 95%CI -1.93 to 1.33 days; 3 studies, n=527) and quality of life (MD -1.51, 95%CI -10.04 to 7.02; 1 study, n=131).  Low-certainty evidence suggests that, compared to MR by other professionals, MR by pharmacists may reduce medication errors (OR 0.21, 95%CI 0.09 to 0.48; 8 studies, n=2648) and may increase ADEs (OR 1.34, 95%CI 0.73 to 2.44; 3 studies, n=2873). Compared to MR by other professionals, MR by pharmacists may have little to no effect on length of stay (MD -0.25, 95%CI -1.05 to 0.56; 6 studies, 3983). Moderate-certainty evidence shows that this intervention probably has little to no effect on mortality during hospitalisation (risk ratio (RR) 0.99, 95%CI 0.57 to 1.7; 2 studies, n=1000), and on readmissions at one month (RR 0.93, 95%CI 0.76 to 1.14; 2 studies, n=997); and low-certainty evidence suggests that the intervention may have little to no effect on quality of life (MD 0.00, 95%CI -14.09 to 14.09; 1 study, n=724).  Low-certainty evidence suggests that database-assisted MR conducted by pharmacists, versus unassisted MR conducted by pharmacists, may reduce potential ADEs (OR 0.26, 95%CI 0.10 to 0.64; 2 studies, n=3326), and may have no effect on length of stay (MD 1.00, 95%CI -0.17 to 2.17; 1 study, n=311).  Low-certainty evidence suggests that MR performed by trained pharmacist technicians, versus pharmacists, may have little to no difference on length of stay (MD -0.30, 95%CI -2.12 to 1.52; 1 study, n=183). However, the CI is compatible with important beneficial and detrimental effects. Low-certainty evidence suggests that MR before admission may increase the identification of discrepancies compared with MR after admission (MD 1.27, 95%CI 0.46 to 2.08; 1 study, n=307). However, the CI is compatible with important beneficial and detrimental effects. Moderate-certainty evidence shows that multimodal interventions probably increase discrepancy resolutions compared to usual care (RR 2.14, 95%CI 1.81 to 2.53; 1 study, n=487). Computerised physician order entry (CPOE)/clinical decision support systems (CDSS) Moderate-certainty evidence shows that CPOE/CDSS probably reduce medication errors compared to paper-based systems (OR 0.74, 95%CI 0.31 to 1.79; 2 studies, n=88).  Moderate-certainty evidence shows that, compared with standard CPOE/CDSS, improved CPOE/CDSS probably reduce medication errors (OR 0.85, 95%CI 0.74 to 0.97; 2 studies, n=630). Low-certainty evidence suggests that prioritised alerts provided by CPOE/CDSS may prevent ADEs compared to non-prioritised (inconsequential) alerts (MD 1.98, 95%CI 1.65 to 2.31; 1 study; participant numbers unavailable). Barcode identification of participants/medications Low-certainty evidence suggests that barcoding may reduce medication errors (OR 0.69, 95%CI 0.59 to 0.79; 2 studies, n=50,545). Reduced working hours Low-certainty evidence suggests that reduced working hours may reduce serious medication errors (RR 0.83, 95%CI 0.63 to 1.09; 1 study, n=634). However, the CI is compatible with important beneficial and detrimental effects. Feedback on prescribing errors Low-certainty evidence suggests that feedback on prescribing errors may reduce medication errors (OR 0.47, 95%CI 0.33 to 0.67; 4 studies, n=384). Dispensing system Low-certainty evidence suggests that dispensing systems in surgical wards may reduce medication errors (OR 0.61, 95%CI 0.47 to 0.79; 2 studies, n=1775). AUTHORS' CONCLUSIONS: Low- to moderate-certainty evidence suggests that, compared to usual care, medication reconciliation, CPOE/CDSS, barcoding, feedback and dispensing systems in surgical wards may reduce medication errors and ADEs. However, the results are imprecise for some outcomes related to medication reconciliation and CPOE/CDSS. The evidence for other interventions is very uncertain. Powered and methodologically sound studies are needed to address the identified evidence gaps. Innovative, synergistic strategies -including those that involve patients- should also be evaluated.

Workplace interventions to increase colorectal cancer screening: health technology assessment / Intervenciones en ámbito laboral para incrementar el rastreo de cáncer colorrectal: evaluación de tecnología sanitaria

RESUMEN INTRODUCCIÓN : El cáncer de colon y recto (CCR) es la tercera neoplasia más frecuente y la cuarta causa de muerte por cáncer a nivel mundial. En Argentina es la segunda neoplasia maligna más frecuente, con el 11,8% de los casos. El objetivo del informe fue evaluar la evidencia sobre la eficacia de intervenciones efectuadas en el ámbito laboral para incrementar el rastreo de CCR. MÉTODOS : Se realizó una búsqueda en bases de datos bibliográficas, buscadores genéricos de Internet y sitios ministeriales de salud y educación nacionales. RESULTADOS : Se incluyeron dos estudios clínicos aleatorizados (ECA) por conglomerados, un ECA, cinco estudios de implementación sin grupo control, reportes de programas y guías de prácticas clínicas de rastreo del CCR desarrollados en países de América y una guía europea. Las intervenciones en el ámbito laboral son eficaces para aumentar la tasa de rastreo. La entrega de kits para test de sangre oculta en materia fecal (TSOMF) fue la intervención más utilizada, seguida por distribución de información y sesiones educativas. Se vio mayor eficacia de las intervenciones en quienes contaban con historia familiar de CCR o recibían información sobre el riesgo individual de desarrollar la enfermedad. Los encuentros educativos en ámbitos laborales son un entorno aceptable para difundir información y distribuir kits para TSOMF. DISCUSIÓN : Un abordaje compuesto por intervenciones en el ámbito laboral podría incrementar la tasa de rastreo de CCR en la población general.

ABSTRACT INTRODUCTION : Colorectal cáncer (CRC) is the thirdmost frequent neoplasm and the fourth cause of death from cáncer worldwide. In Argentina it is the second most frequent malignancy, with 11.8% of the cases. The objective of the study was to assess the evidence on the effectiveness of workplace interventions aimed at increasing the screening rate of CRC. METHODS : A search was conducted in bibliographic databases, generic Internet search engines, and national health and education ministry websites. RESULTS : Two cluster randomized clinical trials (RCTs), one RCT, five non-control group implementation studies, program reports and clinical practice guidelines for CRC screening developed in American countries as well as a European guideline were included. Workplace interventions are effective for increasing the rate of screening. The delivery of faecal occult blood test (FOBT) kits was the most frequently usedintervention, followed by information distribution and educational meetings. Interventions were more effective in those who had a family history of CRC or who were informed of the individual risk of developing the disease. Educational meetings in the workplace are an acceptable environment for disseminating information and distributing FOBT kits. DISCUSSION : An approach consisting of workplace interventions could increase the rate of CRC screening in the general population.

Intervenciones en ámbito laboral para incrementar el rastreo de cáncer colorrectal evaluación de tecnología sanitaria / Workplace interventions to increase colorectal cancer screening: health technology assessment

INTRODUCCIÓN: El cáncer de colon y recto (CCR) es la tercera neoplasia más frecuente y la cuarta causa de muerte por cáncer a nivel mundial. En Argentina es la segunda neoplasia maligna más frecuente, con el 11,8% de los casos. El objetivo del informe fue evaluar la evidencia sobre la eficacia de intervenciones efectuadas en el ámbito laboral para incrementar el rastreo de CCR. MÉTODOS: Se realizó una búsqueda en bases de datos bibliográficas, buscadores genéricos de Internet y sitios ministeriales de salud y educación nacionales. RESULTADOS: Se incluyeron dos estudios clínicos aleatorizados (ECA) por conglomerados, un ECA, cinco estudios de implementación sin grupo control, reportes de programas y guías de prácticas clínicas de rastreo del CCR desarrollados en países de América y una guía europea. Las intervenciones en el ámbito laboral son eficaces para aumentar la tasa de rastreo. La entrega de kits para test de sangre oculta en materia fecal (TSOMF) fue la intervención más utilizada, seguida por distribución de información y sesiones educativas. Se vio mayor eficacia de las intervenciones en quienes contaban con historia familiar de CCR o recibían información sobre el riesgo individual de desarrollar la enfermedad. Los encuentros educativos en ámbitos laborales son un entorno aceptable para difundir información y distribuir kits para TSOMF. DISCUSIÓN: Un abordaje compuesto por intervenciones en el ámbito laboral podría incrementar la tasa de rastreo de CCR en la población general

[Influence of intra-abdominal hypertension on the respiratory mechanics of critically ill adult patients with invasive mechanical ventilation]. / Influencia de la hipertensión intraabdominal en la mecánica respiratoria de pacientes adultos críticamente enfermos con ventilación mecánica invasiva.

Objective: to describe the modifications in respiratory mechanics, the proposed ventilatory strategies and the correct positioning of critically ill adult patients with HIA and ACS with the requirement of IMV in the ICU.Data sources: the bibliographic search was carried out in Pubmed, Cochrane Library and Google Scholar® without restriction of the language with publication date until July 31, 2019. Study selection: adult patients with a requirement for IMV and diagnosis of HIA and / or ACS who have performed the ventilatory monitoring and patient positioning analysis. Laboratory studies on animals will be excluded. Data extraction: the initial search identified 681 studies, of which 30 articles were included for data analysis. Synthesis of data: patients with VMI requirement should be allowed to increase airway pressures and use of high PEEP; Only in specific cases could recruitment and prone maneuvering be applied to maintain adequate alveolar ventilation. Inverted Trendelemburg positioning is useful, as it improves respiratory mechanics and prevents abdominal compression. Conclusions: alterations in respiratory mechanics produce a decrease in thoracic compliance, lung volumes and oxygenation disorders. The ventilatory strategy should consider Vt between 6-8 ml / kg according to predicted body weight, working pressure less than 14 cm H2O, plateau pressure of 30 cm H2O + PIA / 2 and sufficient levels of PEEP to prevent lung collapse in order to expiration.

Objetivo: describir las modificaciones en la mecánica respiratoria, las estrategias ventilatorias propuestas y el correcto posicionamiento de los pacientes adultos críticamente enfermos con HIA y SCA con requerimiento de VMI en UCI.Fuentes de datos: la búsqueda bibliográfica fue realizada en Pubmed, Cochrane Library y Google Académico® sin restricción del lenguaje con fecha de publicación hasta el 31 de julio de 2019. Selección de los estudios: pacientes adultos con requerimiento de VMI y diagnóstico de HIA y/o SCA que hayan realizado el análisis de monitoreo ventilatorio y posicionamiento del paciente. Se excluirán los estudios de laboratorio realizados en animales. Extracción de datos: la búsqueda inicial identificó 681 estudios, de los cuales se incluyeron 30 artículos para el análisis de datos. Síntesis de datos: los pacientes con requerimiento de VMI se debe permitir el aumento de las presiones en la vía aérea y utilización de PEEP elevada; sólo en casos específicos se podrían aplicar maniobras de reclutamiento y decúbito prono para mantener una ventilación alveolar adecuada. El posicionamiento en Trendelemburg invertido es de utilidad, ya que mejora la mecánica respiratoria y evita la compresión abdominal. Conclusiones: las alteraciones de la mecánica respiratoria producen una disminución de la compliance torácica, volúmenes pulmonares y trastornos en la oxigenación. La estrategia ventilatoria debe contemplar Vt entre 6-8 ml/kg según peso corporal predicho, presión de trabajo menor a 14 cm H2O, presión meseta de 30 cm H2O+PIA/2 y niveles suficientes de PEEP para prevenir el colapso pulmonar a fin de espiración.

The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.

BACKGROUND: Worldwide, smoking tobacco causes 7 million deaths annually, and this toll is expected to increase, especially in low-income and middle-income countries. In Latin America, smoking is a leading risk factor for death and disability, contributes to poverty, and imposes an economic burden on health systems. Despite being one of the most effective measures to reduce smoking, tobacco taxation is underused and cigarettes are more affordable in Latin America than in other regions. Our aim was to estimate the tobacco-attributable burden on mortality, disease incidence, quality of life lost, and medical costs in 12 Latin American countries, and the expected health and economic effects of increasing tobacco taxes. METHODS: In this modelling study, we developed a Markov probabilistic microsimulation economic model of the natural history, medical costs, and quality-of-life losses associated with the most common tobacco-related diseases in 12 countries in Latin America. Data inputs were obtained through a literature review, vital statistics, and hospital databases from each country: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, Honduras, Mexico, Paraguay, Peru, and Uruguay. The main outcomes of the model are life-years, quality-adjusted life-years, disease events, hospitalisations, disease incidence, disease cost, and healthy years of life lost. We estimated direct medical costs for each tobacco-related disease included in the model using a common costing methodology for each country. The disease burden was estimated as the difference in disease events, deaths, and associated costs between the results predicted by the model for current smoking prevalence and a hypothetical cohort of people in each country who had never smoked. The model estimates the health and financial effects of a price increase of cigarettes through taxes, in terms of disease and health-care costs averted, and increased tax revenues. FINDINGS: In the 12 Latin American countries analysed, we estimated that smoking is responsible for approximately 345 000 (12%) of the total 2 860 921 adult deaths, 2·21 million disease events, 8·77 million healthy years of life lost, and $26·9 billion in direct medical costs annually. Health-care costs attributable to smoking were estimated to represent 6·9% of the health budgets of these countries, equivalent to 0·6% of their gross domestic product. Tax revenues from cigarette sales cover 36·0% of the estimated health expenditures caused by smoking. We estimated that a 50% increase in cigarette price through taxation would avert more than 300 000 deaths, 1·3 million disease events, gain 9 million healthy life-years, and save $26·7 billion in health-care costs in the next 10 years, with a total economic benefit of $43·7 billion. INTERPRETATION: Smoking represents a substantial health and economic burden in these 12 countries of Latin America. Tobacco tax increases could successfully avert deaths and disability, reduce health-care spending, and increase tax revenues, resulting in large net economic benefits. FUNDING: International Development Research Centre (IDRC), Canada.

Características epidemiológicas y factores de riesgo de los pacientes adultos con Debilidad Adquirida en la Unidad de Cuidados Intensivos / Epidemiological Characteristics and Risk Factors of Adult Patients with Intensive Care Unit-Acquired Weakness

Introducción: La debilidad adquirida en la unidad de cuidados intensivos (DAUCI) compromete tanto a los músculos de las extremidades como el diafragma, asociándose con variables de resultado negativas. El objetivo del estudio fue describir las características epidemiológicas e incidencia de DAUCI en adultos con requerimiento de ventilación mecánica invasiva (VMI) mayor a 72 horas en un Hospital General de Agudos de la Ciudad de Buenos Aires. Método: Estudio de cohorte retrospectivo. Se incluyeron pacientes adultos con requerimiento de VMI por más de 72 horas en la Unidad de Cuidados Intensivos (UCI). Las principales variables de interés registradas fueron: incidencia de DAUCI, días de VMI, estadía y mortalidad tanto en UCI como hospitalaria. Resultados: Se incluyeron 262 pacientes de los cuales 87 (33,21%) intercurrieron con debilidad. No se establecieron diferencias estadísticamente significativas entre los pacientes con y sin DAUCI para las variables edad, motivo de ingreso a VMI, número de antecedentes personales y mortalidad tanto en UCI como hospitalaria. En el presente estudio se establecieron como factores de riesgo independiente al sexo femenino (OR: 1,98; IC 95%: 1,02 ­3,81), delirio (OR 8,4; IC 95%: 4,38-16,11) y días de VMI (OR: 1,05; IC 95%: 1,02-1,08). Conclusiones: El presente estudio nos permitió conocer la incidencia y las características epidemiológicas de los pacientes que presentan DAUCI en una UCI del sistema público de salud de Argentina. Se observó que el sexo femenino, los días de VMI y el delirio en UCI fueron factores de riesgo independiente para DAUCI.

Epidemiological Characteristics and Risk Factors of Adult Patients with Intensive Care Unit-Acquired Weakness

Introduction: Intensive care unit-acquired weakness (ICUAW) affects the muscles of the limbs and diaphragm; and is associated with negative outcome variables. The purpose of this study was to describe the epidemiological characteristics and incidence of ICUAW in adults requiring invasive mechanical ventilation (IMV) for more than 72 hours in a General Hospital for Acute Diseases in the City of Buenos Aires. Method: Retrospective cohort study. We included adult patients requiring IMV for more than 72 hours in the Intensive Care Unit (ICU). The main recorded variables of interest were: incidence of ICUAW, days of IMV, length of stay and mortality both in the ICU and in the hospital. Results: 262 patients were included in the study; 87 of them (33.21%) developed weakness. No statistically significant differences were established between patients with and without ICUAW regarding the variables of age, reason for admission to IMV, medical history and mortality both in the ICU and the hospital. In this study, the variables established as independent risk factors were: female gender (OR: 1,98; 95% CI: 1.02-3.81), delirium (OR 8.4; 95% CI: 4.38-16.11) and days of IMV (OR: 1.05; 95% CI: 1.02-1.08). Conclusions: This study allowed us to know the incidence and epidemiological characteristics of patients with ICUAW in an ICU of the public health system of Argentina. It was observed that female gender, days of IMV and delirium at the ICU were independent risk factors for ICUAW.

Smoke-Free Air Interventions in Seven Latin American Countries: Health and Financial Impact to Inform Evidence-Based Policy Implementation.

INTRODUCTION: Disease burden due to tobacco smoking in Latin America remains very high. The objective of this study was to evaluate the potential impact of implementing smoke-free air interventions on health and cost outcomes in Argentina, Bolivia, Brazil, Chile, Colombia, Mexico, and Peru, using a mathematical model. AIMS AND METHODS: We built a probabilistic Monte Carlo microsimulation model, considering natural history, direct health system costs, and quality of life impairment associated with main tobacco-related diseases. We followed individuals in hypothetical cohorts and calculated health outcomes on an annual basis to obtain aggregated 10-year population health outcomes (deaths and events) and costs. To populate the model, we completed an overview and systematic review of the literature. Also, we calibrated the model comparing the predicted disease-specific mortality rates with those coming from local national statistics. RESULTS: With current policies, for the next 10 years, a total of 137 121 deaths and 917 210 events could be averted, adding 3.84 million years of healthy life and saving USD 9.2 billion in these seven countries. If countries fully implemented smoke-free air strategies, it would be possible to avert nearly 180 000 premature deaths and 1.2 million events, adding 5 million healthy years of life and saving USD 13.1 billion in direct healthcare. CONCLUSIONS: Implementing the smoke-free air strategy would substantially reduce deaths, diseases, and health care costs attributed to smoking. Latin American countries should not delay the full implementation of this strategy. IMPLICATIONS: Tobacco smoking is the single most preventable and premature mortality cause in the world. The Framework Convention on Tobacco Control, supported by the World Health Organization, introduced a package of evidence-based measures for tobacco control. This study adds quality evidence on the potential health effects and savings of implementing smoke-free air policies in countries representing almost 80% of the Latin America and the Caribbean population.

The quality of clinical practice guidelines for preoperative care using the AGREE II instrument: a systematic review.

BACKGROUND: Our aim was to summarize and compare relevant recommendations from evidence-based CPGs (EB-CPGs). METHODS: Systematic review of clinical practice guidelines. DATA SOURCES: PubMed, EMBase, Cochrane Library, LILACS, Tripdatabase, and additional sources. In July 2017, we searched CPGs that were published in the last 10 years, without language restrictions, in electronic databases, and also searched specific CPG sources, reference lists, and consulted experts. Pairs of independent reviewers selected EB-CPGs and rated their methodological quality using the AGREE-II instrument. We summarized recommendations, its supporting evidence, and strength of recommendations according to the GRADE methodology. RESULTS: We included 16 EB-CPGs out of 2262 references identified. Only nine of them had searches within the last 5 years and seven used GRADE. The median (percentile 25-75) AGREE-II scores for rigor of development was 49% (35-76%) and the domain "applicability" obtained the worst score 16% (9-31%). We summarized 31 risk stratification recommendations, 21.6% of which were supported by high/moderate quality of evidence (41% of them were strong recommendations), and 16 therapeutic/preventive recommendations, 59% of which were supported by high/moderate quality of evidence (75.7% strong). We found inconsistency in ratings of evidence level. "Guidelines' applicability" and "monitoring" were the most deficient domains. Only half of the EB-CPGs were updated in the past 5 years. CONCLUSIONS: We present many strong recommendations that are ready to be considered for implementation as well as others to be interrupted, and we reveal opportunities to improve guidelines' quality.

Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study.

BACKGROUND AND AIMS: Ulcerative Colitis (UC) and Crohn's Disease (CD) have a major impact on quality of life and medical costs. The aim of the study was to estimate the prevalence, incidence and clinical phenotypes of Inflammatory Bowel Disease (IBD) cases in Mexico and Colombia. METHODS: We analyzed official administrative and health databases, used mathematical modelling to estimate the incidence and complete prevalence, and performed a case-series of IBD patients at a referral center both in Mexico and Colombia. RESULTS: The age-adjusted complete prevalence of UC per 100,000 inhabitants for 2015/2016 ranged from 15.65 to 71.19 in Mexico and from 27.40 to 69.97 in Colombia depending on the model considered. The prevalence of CD per 100,000 inhabitants in Mexico ranged from 15.45 to 18.08 and from 16.75 to 18.43 in Colombia. In Mexico, the age-adjusted incidence of UC per 100,000 inhabitants per year ranged from 0.90 to 2.30, and from 0.55 to 2.33 in Colombia. The incidence for CD in Mexico ranged from 0.35 to 0.66 whereas in Colombia, the age-adjusted incidence of CD ranged from 0.30 to 0.57. The case-series included 200 IBD patients from Mexico and 204 patients from Colombia. The UC/CD prevalence ratio in Mexico and Colombia was 1.50:1 and 4.5:1 respectively. In Mexico, the female/male prevalence ratio for UC was 1.50:1 and 1.28:1 for CD, while in Colombia this ratio was 0.68:1 for UC and 0.8:1 for CD. In Mexico the relapse rate for UC was 63.3% and 72.5% for CD, while those rates in Colombia were 58.2% for UC and 58.3% for CD. CONCLUSIONS: The estimated burden of disease of IBD in Mexico and Colombia is not negligible. Although these findings need to be confirmed by population-based studies, they are useful for decision-makers, practitioners and patients with this condition.

Conducting and Disseminating Epidemiological Systematic Reviews in Latin America and the Caribbean: Pitfalls and Lessons Learned.

OBJECTIVES: To describe the experience, pitfalls, and lessons learned in conducting and disseminating epidemiological systematic reviews (SRs) in Latin America and the Caribbean between 2007 and 2016. METHODS: We used a mixed-methods approach, including a descriptive cross-sectional study and a qualitative study of pitfalls and lessons learned. The following end points were analyzed: number of primary research studies included, country of origin, study design, risk of bias, citations in social media, number of researchers and experts involved, and time devoted by them to conduct SRs. Data for the qualitative study were collected through sessions with multiprofessional focus groups of the reviewers' core team held from February to March 2016. We performed a thematic analysis of the following domains: sources of information, evidence quantity and quality, statistical analysis, and dissemination of findings in both academic and social media. RESULTS: A total of 19 SRs were produced, including 1016 primary research studies. Brazil (35%) and Argentina (19%) contributed the largest number of studies. The most frequent design was cross-sectional (35%). Only 27% of the studies included in the SRs were judged as having a low risk of bias. We identified key challenges at different stages of the process. We found substantial difficulties in all domains derived from the thematic analysis and proposed potential solutions for each of them. CONCLUSIONS: There are large gaps in epidemiological evidence from primary research, particularly from population-based studies. Special approaches are needed to identify, assess, synthesize, interpret, and disseminate epidemiological evidence from Latin America and the Caribbean.

Cannabinoides en pacientes con trastornos del espectro autista / Cannabinoids in patients with autism spectrum disorders

CONTEXTO CLÍNICO: Los trastornos del espectro autista (TEA) son un grupo de alteraciones o déficit del desarrollo de características crónicas y que afectan de manera distinta a cada paciente. Los TEA se definen como una disfunción neurológica crónica con fuerte base genética que desde edades tempranas se manifiesta en una serie de síntomas basados en la tríada de Wing que incluye: la comunicación, flexibilidad e imaginación; e interacción social. Dichas manifestaciones aparecen en la infancia con tendencia a persistir hasta la adolescencia y la edad adulta. En la mayoría de los casos se manifiestan en los primeros 5 años de vida.2,3 Se calcula que 1 de cada 160 niños tiene TEA, esta estimación representa una cifra media, ya que la prevalência observada varía considerablemente entre los distintos estudios indentificados. TECNOLOGÍA: La planta Cannabis sativa, habitualmente conocida como marihuana, contiene más de 500 compuestos. Los más abundantes son los de la familia de los cannabinoides. El componente psicoactivo principal de la marihuana es el cannabinoide ∆9-tetrahidrocannabinol (THC). El segundo compuesto más prevalente y más estudiado que presenta propiedades psicoactivas mínimas o ausentes, es el cannabidiol. Otros cannabinoidessin propiedades psicoactivas que han sido estudiados son el dronabinol y la nabilona. Para producirsus efectos, los cannabinoides activan los receptores del sistema endocannabinoide. Existen dos tipos principales de receptores en este sistema (CB1 y CB2). El receptor CB1 se ubica principalmente en el sistema nervioso central y el CB2 en las células inmunes. El sistema endocannabinoide puede tener un rol regulatorio de la excitación neuronal. OBJETIVO: Evaluar la evidencia disponible acerca de la eficacia, seguridad y aspectos relacionados a las políticas de cobertura del uso de cannabinoides para el tratamiento de pacientes con transtornos del espectro autista. MÉTODOS: Se realizó una búsqueda en las principales bases de datos bibliográficas (incluyendo Medline, Cochrane y CRD), en buscadores genéricos de Internet, agencias de evaluación de tecnologias sanitarias y financiadores de salud utilizando la siguiente estrategia:(Cannabis[Mesh] OR Medical Marijuana[Mesh] OR Endocannabinoids[Mesh] OR Cannabinoids[Mesh] OR Marijuana[tiab] OR Cannabi*[tiab] OR Dronabinol[tiab] OR Endocannabi*[tiab]) AND (AutismSpectrumDisorder[Mesh] OR AutisticDisorder[Mesh] OR Autism[tiab] OR Autistic*[tiab]). Para la selección de estudios se incluyeron sólo estudios primarios de cualquier diseño con um número de pacientes igual o superior a 10. Además se incluyeron evaluaciones de tecnologias sanitarias y económicas, guías de práctica clínica (GPC) y políticas de cobertura de otros sistemas de salud cuando estaban disponibles. RESULTADOS: No se hallaron estudios primarios que cumplan con los criterios establecidos. Sólo se encontro una evaluación de tecnología sanitaria (ETS). Una ETS realizada por la ANMAT en el año 2016 en Argentina, evaluó el uso de cannabinoides para el tratamiento de sujetos con TEA. Los autores concluyen que los estudios disponibles no aportan la evidencia suficiente que justifique el uso de los cannabinoides en el tratamiento del TEA. Se encontró un estudio en curso registrado en la base de datos de Ensayos Clínicos del Instituto Nacional de Salud de los Estados Unidos (ClinicalTrials.gov). Se trata de un ensayo clínico aleatorizado (ECA) doble ciego controlado con placebo, que se encuentra en etapa de reclutamiento de pacientes (NCT: 02956226). CONCLUSIONES: No se encontró evidencia científica disponible que permita establecer la efectividad del uso de cannabinoides para el tratamiento de pacientes con trastornos del espectro autista. Las guías de práctica clínica consultadas no hacen referencia a la utilización de esta tecnología para trastornos del espectro autista y no se identificaron políticas de cobertura que contemplen su uso.

Incidencia de infecciones respiratorias en pacientes traqueostomizados en un centro de desvinculación de la ventilación mecánica y rehabilitación / Incidence of respiratory tract infections in tracheostomized patients hospitalized in a weaning and rehabilitation center

Objetivos: Describir la incidencia de infecciones respiratorias (IR) en pacientes traqueostomizados (TQT) internados en un centro de desvinculación de la ventilación mecánica y rehabilitación (CDVMR). Identificar factores de riesgo (FR) para el desarrollo de IR. Materiales y métodos: Se realizó un estudio de casos y controles anidado en una cohorte. La variable utilizada para el apareamiento fue la edad. Se incluyeron a todos los pacientes TQT internados durante el período de marzo del 2013 a febrero del 2015. Se registró la incidencia de IR. Resultado: Se incluyeron 167 pacientes, registrándose 73 eventos de IR en 46 pacientes. La incidencia acumulada fue de 27,5% y la tasa de incidencia fue de 2,22 eventos/1000 días de estadía. De los 73 eventos registrados, se obtuvieron rescates bacteriológicos en 50 de ellos, siendo Pseudomonas aeruginosa (34,3%) el microorganismo más prevalente. Los valores más bajos de albúmina resultaron ser un FR para el desarrollo de IR (p 0.001, OR 5.82, IC 2.08-16.2). Los valores más altos de hemoglobina de ingreso se comportaron como factor protector (p 0.048, OR 0.74, IC 0.55-0.99). Se establecieron como FR para el evento IR: ingresar con diagnóstico de ACV (p 0.025, OR 3.45 1.16-10.2), Parkinson (p 0.011, OR 18.9, IC 1.93-185) o ELA (p 0.013, OR 6.34, IC 1.47-27.2). Conclusión: Se logró determinar por primera vez en nuestro medio la incidencia de IR en pacientes TQT y los patógenos más comunes, aunque esto necesita contraste con otros CDVMR. La asociación encontrada entre los valores de albúmina y el posterior desarrollo de IR podría estar relacionada más a un sesgo probabilístico que a una diferencia clínica significativa. Los pacientes con determinadas enfermedades neurológicas presentan mayor riesgo de IR.

Incidence of respiratory tract infections in tracheostomized patients hospitalized in a weaning and rehabilitation center

Objectives: To describe the incidence of respiratory tract infections (RTIs) in tracheostomized patients hospitalized in a weaning and rehabilitation center (WRC) and to identify risk factors (RFs) for the development of RTI. Materials and methods: A nested case-control study was conducted. Age was used as the matching variable. All tracheostomized patients who were hospitalized from March, 2013, to February, 2015, were included. The incidence of RTI was recorded. Results: A total of 167 patients were included, with 73 RTI episodes being recorded in 46 patients (27.5%). Cumulative incidence was 27.5%, and incidence rate was 2.22 episodes per 1,000 days of stay. Bacteria were recovered in 50 of the 73 episodes recorded, with Pseudomonas aeruginosa being the most prevalent organism (34.3%). The lowest albumin values proved to be a RF for the development of RTI (p 0.001, odds ratio [OR] 5.82, confidence interval [CI] 2.08-16.2). The highest hemoglobin values on admission acted as protective factors (p 0.048, OR 0.74, CI 0.55-0.99). Diagnoses of stroke (p 0.025, OR 3.45, CI 1.16-10.2), Parkinson (p 0.011, OR 18.9, CI 1.93-185) or amyotrophic lateral sclerosis (ALS) (p 0.013, OR 6.34, IC 1.47-27.2) on admission were established as risk factors for the development of RTI. Conclusion: For the first time in our setting, it was possible to determine the incidence of RTI in tracheostomized patients and the most common pathogens, although comparison with other WRCs is needed. The association found between albumin values and the subsequent development of RTI might be more related to an incidental finding than to a significant clinical difference. Patients with certain neurologic diseases are at increased risk for RTI.

Effect of tracheostomy tube on work of breathing: Comparison of pre- and post-decannulation.

OBJECTIVE: To describe and compare the work of breathing (WOB) during spontaneous breathing under four conditions: (1) breathing through a tracheostomy tube with an inflated cuff, (2) breathing through the upper airway (UA) with a deflated cuff and occluded tube, (3) breathing through the UA with an occluded cuffless tube, and (4) postdecannulation. PATIENTS AND METHODS: Patients who tolerated an occluded cuffless tube were included. Ventilatory variables and esophageal pressure were recorded. The pressure-time product (PTP), PTP/min, and PTP/min/tidal volume (PTP/min/VT) were measured. Each condition was measured for 5 min with a 15 min time interval between evaluations. Quantitative data are expressed as mean ± standard deviation. Single-factor analysis of variance was used, and the Games-Howell test was used for post hoc analysis of comparisons between group means (P ≤ 0.05). RESULTS: Eight patients were studied under each of the four conditions described above. Statistically significant differences were found for PTP, PTP/min, and PTP/min/VT. In the post hoc analysis for PTP, significant differences among all conditions were found. For PTP/min, there was no significant difference between Conditions 2 and 4 (P = 0.138), and for PTP/min/VT, there was no significant difference between Conditions 1 and 2 (P = 0.072) or between Conditions 2 and 3 (P = 0.106). A trend toward a higher PTP, PTP/min, and PTP/min/VT was observed when breathing through a cuffless tracheostomy tube. CONCLUSION: The four conditions differed with respect to WOB. Cuff inflation could result in a reduced WOB because there is less dead space. Cuffless tracheostomy tubes generate increased WOB, perhaps due to the material deformity caused by body temperature.

Características de los pacientes desvinculados de la ventilación mecánica invasiva: Un estudio multicéntrico / Characteristics of Patients Weaning From Invasive Mechnical Ventilation. A multicenter Study

El proceso de weaning incluye la liberación del paciente del soporte ventilatorio y del tubo orotraqueal y se clasifica en simple, dificultoso y prolongado, basado en la dificultad y la duración del mismo. El objetivo fue describir las características epidemiológicas de pacientes desvinculados exitosamente de la ventilación mecánica invasiva y establecer asociaciones entre los tipos de weaning y las variables que influyeron en la evolución de las mismas asociadas a la mortalidad. Realizamos un estudio de cohorte prospectivo, analítico, longitudinal y multicéntrico en tres unidades de terapia intensiva de la Ciudad Autónoma de Buenos Aires, Argentina. Fueron incluidos sujetos que requirieron ventilación mecánica invasiva mayor a 12hs. y desvinculados exitosamente. Las variables estudiadas fueron tipo de weaning, tiempo en ventilación mecánica invasiva, falla de extubación, estadía y mortalidad en terapia intensiva. La prevalencia del weaning simple, dificultoso y prolongado correspondió a un 52.2% (95/182), 25.8% (47/182) y 22% (40/182), respectivamente. Aumentó el promedio de días de ventilación mecánica invasiva a 3,5 cada vez que cambió la categoría (Coefciente B: 3.5; SE 0.6). Aquellos pacientes que fallaron la extubación presentaron mayor riesgo de realizar weaning prolongado ( OR = 23; IC95%: 3.55-149.45). No se halló asociación entre la mortalidad y el tipo de weaning (OR = 0.68; IC95%: 0.31-1.51). En conclusión, no se asoció el tipo de weaning con mortalidad en la terapia intensiva. La falla de extubación, la traqueostomia y la presencia de delirio se asociaron con mayores días de ventilación mecánica invasiva.

The weaning process includes the release from the ventilatory support and endotracheal tube. It is classified into simple, difficult and prolonged, according to its difficulty and duration. The purpose was to describe the epidemiological characteristics of patients successfully weaned from invasive mechanical ventilation and establish associations between the different types of weaning and the variables influencing the evolution of these characteristics associated with mortality. We conducted a multicenter, prospective, longitudinal, analytical cohort study in three intensive care units of the Autonomous City of Buenos Aires, Argentina. We included patients who required invasive mechanical ventilation for more than 12 hours and were successfully weaned from it. The variables to be analyzed were: type of weaning, amount of days the patients received invasive mechanical ventilation, extubation failure and length of stay and mortality in the intensive care unit. The prevalence of simple, difficult or prolonged weaning was 52.2% (95/182), 25.8% (47/182) and 22% (40/182), respectively. The average of days the patients received invasive mechanical ventilation increased to 3.5 every time the category changed (B Coefficient: 3.5; SE [standard error] = 0.6). Patients with extubation failure presented a higher risk of prolonged weaning (OR [odds ratio] = 23; CI [confidence interval] = 95%: 3.55-149.45). No association was found between mortality and type of weaning (OR = 0.68; 95% CI: 0.31-1.51). In conclusion, the type of weaning was not associated with mortality in the intensive care unit. The extubation failure, tracheostomy and presence of delirium were associated with a larger amount of days receiving invasive mechanical ventilation.